{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:32:13Z","timestamp":1789198333055,"version":"build-2803163510"},"reference-count":150,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alpha-1 antitrypsin (AAT) deficiency, characterized by low plasma levels of the serine protease inhibitor AAT, is associated with emphysema secondary to insufficient protection of the lung from neutrophil proteases. Although AAT augmentation therapy with purified AAT protein is efficacious, it requires weekly to monthly intravenous infusion of AAT purified from pooled human plasma, has the risk of viral contamination and allergic reactions, and is costly. As an alternative, gene therapy offers the advantage of single administration, eliminating the burden of protein infusion, and reduced risks and costs. The focus of this review is to describe the various strategies for AAT gene therapy for the pulmonary manifestations of AAT deficiency and the state of the art in bringing AAT gene therapy to the bedside.<\/jats:p>","DOI":"10.1513\/annalsats.201506-344kv","type":"journal-article","created":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T13:23:11Z","timestamp":1472217791000},"page":"S352-S369","source":"Crossref","is-referenced-by-count":44,"title":["Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease"],"prefix":"10.1093","volume":"13","author":[{"given":"Maria J.","family":"Chiuchiolo","sequence":"first","affiliation":[{"name":"Department of Genetic Medicine, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald G.","family":"Crystal","sequence":"additional","affiliation":[{"name":"Department of Genetic Medicine, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,8,1]]},"reference":[{"key":"2026020402535689500_bib1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1172\/JCI110344","article-title":"Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema","volume":"68","author":"Gadek","year":"1981","journal-title":"J Clin Invest"},{"key":"2026020402535689500_bib2","first-page":"403","article-title":"Serpins: the superfamily of plasma serine protease inhibitors","author":"Carrell","year":"1986"},{"key":"2026020402535689500_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9343(88)80066-4","article-title":"Molecular basis of alpha-1-antitrypsin deficiency","volume":"84","author":"Brantly","year":"1988","journal-title":"Am J Med"},{"key":"2026020402535689500_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1164\/ajrccm\/138.2.327","article-title":"Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms","volume":"138","author":"Brantly","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"2026020402535689500_bib5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114578","article-title":"Alpha 1-antitrypsin deficiency, emphysema, and liver disease: genetic basis and strategies for therapy","volume":"85","author":"Crystal","year":"1990","journal-title":"J Clin Invest"},{"key":"2026020402535689500_bib6","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.biocel.2007.12.008","article-title":"The dual role of neutrophil elastase in lung destruction and repair","volume":"40","author":"Lungarella","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"2026020402535689500_bib7","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1056\/NEJMcp0900449","article-title":"Clinical practice: alpha1-antitrypsin deficiency","volume":"360","author":"Silverman","year":"2009","journal-title":"N Engl J Med"},{"key":"2026020402535689500_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1165\/rcmb.2002-0258OC","article-title":"Inhibition of proteinase 3 by [alpha]1-antitrypsin in vitro predicts very fast inhibition in vivo","volume":"29","author":"Duranton","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020402535689500_bib9","doi-asserted-by":"crossref","first-page":"L514","DOI":"10.1152\/ajplung.00099.2003","article-title":"Role of human neutrophil peptides in lung inflammation associated with alpha1-antitrypsin deficiency","volume":"286","author":"Spencer","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026020402535689500_bib10","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2353\/ajpath.2006.060058","article-title":"Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis","volume":"169","author":"Petrache","year":"2006","journal-title":"Am J Pathol"},{"key":"2026020402535689500_bib11","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1074\/jbc.M607976200","article-title":"Alpha1-antitrypsin, old dog, new tricks. Alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP","volume":"282","author":"Janciauskiene","year":"2007","journal-title":"J Biol Chem"},{"key":"2026020402535689500_bib12","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1172\/JCI41196","article-title":"\u03b1-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8","volume":"120","author":"Bergin","year":"2010","journal-title":"J Clin Invest"},{"key":"2026020402535689500_bib13","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2119\/molmed.2011.00145","article-title":"\u03b1-1-Antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection","volume":"17","author":"Shahaf","year":"2011","journal-title":"Mol Med"},{"key":"2026020402535689500_bib14","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2119\/molmed.2011.00196","article-title":"Expanding the clinical indications for \u03b1(1)-antitrypsin therapy","volume":"18","author":"Lewis","year":"2012","journal-title":"Mol Med"},{"key":"2026020402535689500_bib15","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1073\/pnas.1309648110","article-title":"Anti-inflammatory and immunomodulatory properties of \u03b11-antitrypsin without inhibition of elastase","volume":"110","author":"Jonigk","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020402535689500_bib16","doi-asserted-by":"crossref","first-page":"217ra1","DOI":"10.1126\/scitranslmed.3007116","article-title":"The circulating proteinase inhibitor \u03b1-1 antitrypsin regulates neutrophil degranulation and autoimmunity","volume":"6","author":"Bergin","year":"2014","journal-title":"Sci Transl Med"},{"key":"2026020402535689500_bib17","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1515\/hsz-2014-0161","article-title":"Immune-modulating effects of alpha-1 antitrypsin","volume":"395","author":"Ehlers","year":"2014","journal-title":"Biol Chem"},{"key":"2026020402535689500_bib18","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1164\/rccm.201405-0872OC","article-title":"\u03b11-Antitrypsin activates protein phosphatase 2A to counter lung inflammatory responses","volume":"190","author":"Geraghty","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402535689500_bib19","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.ajpath.2014.04.015","article-title":"Unopposed cathepsin G, neutrophil elastase, and proteinase 3 cause severe lung damage and emphysema","volume":"184","author":"Guyot","year":"2014","journal-title":"Am J Pathol"},{"key":"2026020402535689500_bib20","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/infdis\/jiu620","article-title":"Acute phase protein \u03b11-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses","volume":"211","author":"Kaner","year":"2015","journal-title":"J Infect Dis"},{"key":"2026020402535689500_bib21","doi-asserted-by":"crossref","first-page":"L179","DOI":"10.1152\/ajplung.00179.2014","article-title":"\u03b1-1-Antitrypsin variants and the proteinase\/antiproteinase imbalance in chronic obstructive pulmonary disease","volume":"308","author":"Sinden","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026020402535689500_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1513\/pats.201002-020AW","article-title":"Lung disease associated with alpha1-antitrypsin deficiency","volume":"7","author":"Tuder","year":"2010","journal-title":"Proc Am Thorac Soc"},{"key":"2026020402535689500_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1165\/rcmb.2010-0328OC","article-title":"Oxidation of Z \u03b11-antitrypsin by cigarette smoke induces polymerization: a novel mechanism of early-onset emphysema","volume":"45","author":"Alam","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020402535689500_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2119\/molmed.2011.00207","article-title":"Effect of cigarette smoke exposure and structural modifications on the \u03b1-1 antitrypsin interaction with caspases","volume":"18","author":"Lockett","year":"2012","journal-title":"Mol Med"},{"key":"2026020402535689500_bib25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1164\/rccm.201308-1458OC","article-title":"Z \u03b11-antitrypsin confers a proinflammatory phenotype that contributes to chronic obstructive pulmonary disease","volume":"189","author":"Alam","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402535689500_bib26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1378\/chest.95.1.196","article-title":"The alpha 1-antitrypsin gene and its mutations: clinical consequences and strategies for therapy","volume":"95","author":"Crystal","year":"1989","journal-title":"Chest"},{"key":"2026020402535689500_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/ajrccm.158.1.9712017","article-title":"The Alpha-1-Antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin","volume":"158","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402535689500_bib28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/thx.2003.006528","article-title":"Alpha1-antitrypsin deficiency. 4: molecular pathophysiology","volume":"59","author":"Lomas","year":"2004","journal-title":"Thorax"},{"key":"2026020402535689500_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1465-9921-11-44","article-title":"Survival in severe alpha-1-antitrypsin deficiency (PiZZ)","volume":"11","author":"Tanash","year":"2010","journal-title":"Respir Res"},{"key":"2026020402535689500_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1753465812457113","article-title":"Prevalence of \u03b11-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review","volume":"6","author":"de Serres","year":"2012","journal-title":"Ther Adv Respir Dis"},{"key":"2026020402535689500_bib31","doi-asserted-by":"crossref","first-page":"a005801","DOI":"10.1101\/cshperspect.a005801","article-title":"Hepatic fibrosis and carcinogenesis in \u03b11-antitrypsin deficiency: a prototype for chronic tissue damage in gain-of-function disorders","volume":"3","author":"Perlmutter","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2026020402535689500_bib32","doi-asserted-by":"crossref","first-page":"e7042","DOI":"10.5812\/hepatmon.7042","article-title":"Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma","volume":"12","author":"Topic","year":"2012","journal-title":"Hepat Mon"},{"key":"2026020402535689500_bib33","article-title":"Alpha1-antitrypsin deficiency in a patient diagnosed with granulomatosis with polyangiitis","volume-title":"BMJ Case Rep","author":"Inaty","year":"2013"},{"key":"2026020402535689500_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/15412555.2013.765839","article-title":"Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy","volume":"10","author":"Teckman","year":"2013","journal-title":"COPD"},{"key":"2026020402535689500_bib35","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1093\/ndt\/gfu386","article-title":"Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"30","author":"Alberici","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2026020402535689500_bib36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/joim.12239","article-title":"Role of alpha-1 antitrypsin in human health and disease","volume":"276","author":"de Serres","year":"2014","journal-title":"J Intern Med"},{"key":"2026020402535689500_bib37","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.rmed.2013.10.006","article-title":"Disease associations in alpha-1-antitrypsin deficiency","volume":"108","author":"Stone","year":"2014","journal-title":"Respir Med"},{"key":"2026020402535689500_bib38","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.rmr.2014.03.015","article-title":"Molecular pathogenesis of alpha-1-antitrypsin deficiency","volume":"31","author":"Duvoix","year":"2014","journal-title":"Rev Mal Respir"},{"key":"2026020402535689500_bib39","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM198704233161704","article-title":"Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema","volume":"316","author":"Wewers","year":"1987","journal-title":"N Engl J Med"},{"key":"2026020402535689500_bib40","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/jama.1988.03410090091037","article-title":"Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency","volume":"260","author":"Hubbard","year":"1988","journal-title":"JAMA"},{"key":"2026020402535689500_bib41","first-page":"44s","article-title":"Augmentation therapy of alpha 1-antitrypsin deficiency","volume":"9","author":"Hubbard","year":"1990","journal-title":"Eur Respir J Suppl"},{"key":"2026020402535689500_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1126\/science.2017680","article-title":"Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo","volume":"252","author":"Rosenfeld","year":"1991","journal-title":"Science"},{"key":"2026020402535689500_bib43","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/rccm.168.7.818","article-title":"American Thoracic Society\/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency","volume":"168","author":"American Thoracic Society","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402535689500_bib44","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI110360","article-title":"Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects","volume":"68","author":"Gadek","year":"1981","journal-title":"J Clin Invest"},{"key":"2026020402535689500_bib45","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ymthe.2004.08.022","article-title":"Intrapleural administration of a serotype 5 adeno-associated virus coding for alpha1-antitrypsin mediates persistent, high lung and serum levels of alpha1-antitrypsin","volume":"10","author":"De","year":"2004","journal-title":"Mol Ther"},{"key":"2026020402535689500_bib46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ymthe.2005.09.003","article-title":"High levels of persistent expression of alpha1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses","volume":"13","author":"De","year":"2006","journal-title":"Mol Ther"},{"key":"2026020402535689500_bib47","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/hum.2011.053","article-title":"Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing \u03b11-antitrypsin: interim results","volume":"22","author":"Flotte","year":"2011","journal-title":"Hum Gene Ther"},{"key":"2026020402535689500_bib48","doi-asserted-by":"crossref","first-page":"e28511","DOI":"10.4161\/rdis.28511","article-title":"Using antisense technology to develop a novel therapy for \u03b1-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease","volume":"2","author":"Guo","year":"2014","journal-title":"Rare Dis"},{"key":"2026020402535689500_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.molmed.2013.11.006","article-title":"\u03b1-1-Antitrypsin deficiency: clinical variability, assessment, and treatment","volume":"20","author":"Stockley","year":"2014","journal-title":"Trends Mol Med"},{"key":"2026020402535689500_bib50","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11894-013-0367-8","article-title":"Advances in alpha-1-antitrypsin deficiency liver disease","volume":"16","author":"Teckman","year":"2014","journal-title":"Curr Gastroenterol Rep"},{"key":"2026020402535689500_bib51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/pr.2013.190","article-title":"Targeting intracellular degradation pathways for treatment of liver disease caused by \u03b11-antitrypsin deficiency","volume":"75","author":"Wang","year":"2014","journal-title":"Pediatr Res"},{"key":"2026020402535689500_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-007-0748-y","article-title":"Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations","volume":"31","author":"Greene","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"2026020402535689500_bib53","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1172\/JCI112524","article-title":"Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals","volume":"77","author":"Mornex","year":"1986","journal-title":"J Clin Invest"},{"key":"2026020402535689500_bib54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1165\/rcmb.2011-0231OC","article-title":"\u03b11-antitrypsin production by proinflammatory and antiinflammatory macrophages and dendritic cells","volume":"46","author":"van \u2019t Wout","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020402535689500_bib55","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1182\/blood.V77.12.2724.2724","article-title":"Human neutrophils express the alpha 1-antitrypsin gene and produce alpha 1-antitrypsin","volume":"77","author":"du Bois","year":"1991","journal-title":"Blood"},{"key":"2026020402535689500_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0014-5793(94)80695-0","article-title":"Secretion of alpha 1-antitrypsin by alveolar epithelial cells","volume":"346","author":"Venembre","year":"1994","journal-title":"FEBS Lett"},{"key":"2026020402535689500_bib57","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1074\/jbc.272.13.8250","article-title":"Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells","volume":"272","author":"Cichy","year":"1997","journal-title":"J Biol Chem"},{"key":"2026020402535689500_bib58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2559.1982.tb02701.x","article-title":"Morphological identification of alpha-I-antitrypsin in the human small intestine","volume":"6","author":"Geboes","year":"1982","journal-title":"Histopathology"},{"key":"2026020402535689500_bib59","doi-asserted-by":"crossref","first-page":"9485","DOI":"10.1016\/S0021-9258(18)60557-5","article-title":"The alpha 1-antitrypsin gene is expressed in a human intestinal epithelial cell line","volume":"264","author":"Perlmutter","year":"1989","journal-title":"J Biol Chem"},{"key":"2026020402535689500_bib60","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/297428a0","article-title":"Genes for immunoglobulin heavy chains and for alpha 1-antitrypsin are localized to specific regions of chromosome 14q","volume":"297","author":"Cox","year":"1982","journal-title":"Nature"},{"key":"2026020402535689500_bib61","first-page":"868","article-title":"Chromosomal localization of the human alpha 1-antitrypsin gene (PI) to 14q31-32","volume":"37","author":"Schroeder","year":"1985","journal-title":"Am J Hum Genet"},{"key":"2026020402535689500_bib62","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/00365516309051324","article-title":"The electrophoretic alpha1-globulin pattern of serum in alpha1-antitrypsin deficiency","volume":"15","author":"Laurell","year":"1963","journal-title":"Scand J Clin Lab Invest"},{"key":"2026020402535689500_bib63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s004390000434","article-title":"Patterns of haplotype diversity within the serpin gene cluster at 14q32.1: insights into the natural history of the alpha1-antitrypsin polymorphism","volume":"108","author":"Seixas","year":"2001","journal-title":"Hum Genet"},{"key":"2026020402535689500_bib64","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1164\/rccm.201108-1428CI","article-title":"A review of \u03b11-antitrypsin deficiency","volume":"185","author":"Stoller","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402535689500_bib65","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1073\/pnas.78.11.6826","article-title":"Cloning and sequence of cDNA coding for alpha 1-antitrypsin","volume":"78","author":"Kurachi","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020402535689500_bib66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-5793(76)80478-4","article-title":"Amino acid substitution Glu leads to Lys alpha1-antitrypsin PiZ","volume":"65","author":"Jeppsson","year":"1976","journal-title":"FEBS Lett"},{"key":"2026020402535689500_bib67","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/BF01797921","article-title":"Alpha 1-antitrypsin deficiency and liver disease","volume":"14","author":"Birrer","year":"1991","journal-title":"J Inherit Metab Dis"},{"key":"2026020402535689500_bib68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.biochem.78.082107.133320","article-title":"Conformational pathology of the serpins: themes, variations, and therapeutic strategies","volume":"78","author":"Gooptu","year":"2009","journal-title":"Annu Rev Biochem"},{"key":"2026020402535689500_bib69","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/357605a0","article-title":"The mechanism of Z alpha 1-antitrypsin accumulation in the liver","volume":"357","author":"Lomas","year":"1992","journal-title":"Nature"},{"key":"2026020402535689500_bib70","doi-asserted-by":"crossref","first-page":"15989","DOI":"10.1016\/S0021-9258(18)66664-5","article-title":"Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene","volume":"261","author":"Nukiwa","year":"1986","journal-title":"J Biol Chem"},{"key":"2026020402535689500_bib71","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1021\/bi00316a003","article-title":"Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant","volume":"23","author":"Long","year":"1984","journal-title":"Biochemistry"},{"key":"2026020402535689500_bib72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0005-2795(76)90271-3","article-title":"The abnormality of the S variant of human alpha-1-antitrypsin","volume":"453","author":"Owen","year":"1976","journal-title":"Biochim Biophys Acta"},{"key":"2026020402535689500_bib73","first-page":"233","article-title":"Molecular abnormality of PI S variant of human alpha1-antitrypsin","volume":"29","author":"Yoshida","year":"1977","journal-title":"Am J Hum Genet"},{"key":"2026020402535689500_bib74","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1164\/ajrccm\/137.2.364","article-title":"Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase","volume":"137","author":"Ogushi","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"2026020402535689500_bib75","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1378\/chest.12-0564","article-title":"\u03b11-Antitrypsin phenotypes and associated serum protein concentrations in a large clinical population","volume":"143","author":"Bornhorst","year":"2013","journal-title":"Chest"},{"key":"2026020402535689500_bib76","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1164\/ajrccm\/140.5.1494","article-title":"Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency","volume":"140","author":"American Thoracic Society","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"2026020402535689500_bib77","first-page":"109","article-title":"Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline","volume":"19","author":"Marciniuk","year":"2012","journal-title":"Can Respir J"},{"key":"2026020402535689500_bib78","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0140-6736(15)60860-1","article-title":"Intravenous augmentation treatment and lung density in severe \u03b11 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial","volume":"386","author":"Chapman","year":"2015","journal-title":"Lancet"},{"key":"2026020402535689500_bib79","author":"Thompson Healthcare","year":"2010"},{"key":"2026020402535689500_bib80","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1126\/science.3497452","article-title":"Clonal gene therapy: transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo","volume":"237","author":"Garver","year":"1987","journal-title":"Science"},{"key":"2026020402535689500_bib81","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.gt.3301422","article-title":"Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors","volume":"8","author":"Song","year":"2001","journal-title":"Gene Ther"},{"key":"2026020402535689500_bib82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1073\/pnas.89.1.89","article-title":"Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes","volume":"89","author":"Kay","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020402535689500_bib83","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1089\/hum.1992.3.6-641","article-title":"Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo","volume":"3","author":"Kay","year":"1992","journal-title":"Hum Gene Ther"},{"key":"2026020402535689500_bib84","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF01233254","article-title":"Hepatic gene therapy: efficient retroviral-mediated gene transfer into rat hepatocytes in vivo","volume":"19","author":"Kolodka","year":"1993","journal-title":"Somat Cell Mol Genet"},{"key":"2026020402535689500_bib85","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/mgme.1997.2665","article-title":"Expression of human alpha 1 antitrypsin in murine hematopoietic cells in vivo after retrovirus-mediated gene transfer","volume":"63","author":"Saylors","year":"1998","journal-title":"Mol Genet Metab"},{"key":"2026020402535689500_bib86","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/sj.gt.3300933","article-title":"Differential expression and secretion of alpha 1 anti-trypsin between direct DNA injection and implantation of transfected myoblast","volume":"6","author":"Bou-Gharios","year":"1999","journal-title":"Gene Ther"},{"key":"2026020402535689500_bib87","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/sj.gt.3301229","article-title":"Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure","volume":"7","author":"Zhang","year":"2000","journal-title":"Gene Ther"},{"key":"2026020402535689500_bib88","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1089\/hum.1994.5.12-1477","article-title":"Gene expression following direct injection of DNA into liver","volume":"5","author":"Hickman","year":"1994","journal-title":"Hum Gene Ther"},{"key":"2026020402535689500_bib89","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1038\/sj.gt.3302065","article-title":"Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA","volume":"10","author":"Ali\u00f1o","year":"2003","journal-title":"Gene Ther"},{"key":"2026020402535689500_bib90","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1006\/mthe.2001.0278","article-title":"Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver","volume":"3","author":"Chen","year":"2001","journal-title":"Mol Ther"},{"key":"2026020402535689500_bib91","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1152\/jappl.1994.77.1.415","article-title":"No lung toxicity after repeated aerosol or intravenous delivery of plasmid-cationic liposome complexes","volume":"77","author":"Canonico","year":"1994","journal-title":"J Appl Physiol (1985)"},{"key":"2026020402535689500_bib92","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1165\/ajrcmb.10.1.8292378","article-title":"Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits","volume":"10","author":"Canonico","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020402535689500_bib93","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s001090000185","article-title":"Asialofetuin liposome-mediated human alpha1-antitrypsin gene transfer in vivo results in stationary long-term gene expression","volume":"79","author":"Das\u00ed","year":"2001","journal-title":"J Mol Med (Berl)"},{"key":"2026020402535689500_bib94","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1165\/ajrcmb.18.5.2874","article-title":"Transfer of the human alpha1-antitrypsin gene into pulmonary macrophages in vivo","volume":"18","author":"Ferkol","year":"1998","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020402535689500_bib95","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/bbrc.1993.1397","article-title":"In vivo delivery of human alpha 1-antitrypsin gene to mouse hepatocytes by liposomes","volume":"192","author":"Ali\u00f1o","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"2026020402535689500_bib96","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1006\/bbrc.1994.2565","article-title":"Expression of human alpha 1-antitrypsin in mouse after in vivo gene transfer to hepatocytes by small liposomes","volume":"204","author":"Ali\u00f1o","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"2026020402535689500_bib97","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/hum.1996.7.4-531","article-title":"Human alpha 1-antitrypsin gene transfer to in vivo mouse hepatocytes","volume":"7","author":"Ali\u00f1o","year":"1996","journal-title":"Hum Gene Ther"},{"key":"2026020402535689500_bib98","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/0006-2952(96)00038-X","article-title":"Long-term expression of the human alpha1-antitrypsin gene in mice employing anionic and cationic liposome vectors","volume":"51","author":"Crespo","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"2026020402535689500_bib99","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/10430340050015338","article-title":"Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin-deficient subjects: comparison with protein therapy","volume":"11","author":"Brigham","year":"2000","journal-title":"Hum Gene Ther"},{"key":"2026020402535689500_bib100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2013.2527","article-title":"Adenovirus: the first effective in vivo gene delivery vector","volume":"25","author":"Crystal","year":"2014","journal-title":"Hum Gene Ther"},{"key":"2026020402535689500_bib101","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ng0892-372","article-title":"Adenovirus-mediated in vivo gene transfer and expression in normal rat liver","volume":"1","author":"Jaffe","year":"1992","journal-title":"Nat Genet"},{"key":"2026020402535689500_bib102","first-page":"815","article-title":"Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes","volume":"21","author":"Kay","year":"1995","journal-title":"Hepatology"},{"key":"2026020402535689500_bib103","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1165\/ajrcmb.10.4.8136153","article-title":"Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation","volume":"10","author":"Setoguchi","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020402535689500_bib104","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1073\/pnas.89.14.6482","article-title":"Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells","volume":"89","author":"Lemarchand","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020402535689500_bib105","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/01.RES.72.5.1132","article-title":"In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors","volume":"72","author":"Lemarchand","year":"1993","journal-title":"Circ Res"},{"key":"2026020402535689500_bib106","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0298-180","article-title":"Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity","volume":"18","author":"Schiedner","year":"1998","journal-title":"Nat Genet"},{"key":"2026020402535689500_bib107","doi-asserted-by":"crossref","first-page":"12816","DOI":"10.1073\/pnas.96.22.12816","article-title":"Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons","volume":"96","author":"Morral","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020402535689500_bib108","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1089\/hum.1998.9.18-2709","article-title":"High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity","volume":"9","author":"Morral","year":"1998","journal-title":"Hum Gene Ther"},{"key":"2026020402535689500_bib109","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/595830","article-title":"Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses","volume":"199","author":"Calcedo","year":"2009","journal-title":"J Infect Dis"},{"key":"2026020402535689500_bib110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fimmu.2013.00341","article-title":"Humoral immune response to AAV","volume":"4","author":"Calcedo","year":"2013","journal-title":"Front Immunol"},{"key":"2026020402535689500_bib111","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","article-title":"Clades of adeno-associated viruses are widely disseminated in human tissues","volume":"78","author":"Gao","year":"2004","journal-title":"J Virol"},{"key":"2026020402535689500_bib112","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1566523054065057","article-title":"New recombinant serotypes of AAV vectors","volume":"5","author":"Gao","year":"2005","journal-title":"Curr Gene Ther"},{"key":"2026020402535689500_bib113","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat Med"},{"key":"2026020402535689500_bib114","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2174\/156652311796150354","article-title":"Immune responses to AAV in clinical trials","volume":"11","author":"Mingozzi","year":"2011","journal-title":"Curr Gene Ther"},{"key":"2026020402535689500_bib115","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1172\/JCI70314","article-title":"Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression","volume":"123","author":"Mueller","year":"2013","journal-title":"J Clin Invest"},{"key":"2026020402535689500_bib116","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fimmu.2014.00350","article-title":"Cell-mediated immunity to AAV vectors, evolving concepts and potential solutions","volume":"5","author":"Basner-Tschakarjan","year":"2014","journal-title":"Front Immunol"},{"key":"2026020402535689500_bib117","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/hum.2006.113","article-title":"Preclinical characterization of a recombinant adeno-associated virus type 1-pseudotyped vector demonstrates dose-dependent injection site inflammation and dissemination of vector genomes to distant sites","volume":"18","author":"Flotte","year":"2007","journal-title":"Hum Gene Ther"},{"key":"2026020402535689500_bib118","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood-2004-03-0848","article-title":"Systemic protein delivery by muscle-gene transfer is limited by a local immune response","volume":"105","author":"Wang","year":"2005","journal-title":"Blood"},{"key":"2026020402535689500_bib119","doi-asserted-by":"crossref","first-page":"10222","DOI":"10.1128\/JVI.72.12.10222-10226.1998","article-title":"Adeno-associated virus as a vector for liver-directed gene therapy","volume":"72","author":"Xiao","year":"1998","journal-title":"J Virol"},{"key":"2026020402535689500_bib120","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ymthe.2005.05.016","article-title":"Efficient hepatic delivery and expression from a recombinant adeno-associated virus 8 pseudotyped alpha1-antitrypsin vector","volume":"12","author":"Conlon","year":"2005","journal-title":"Mol Ther"},{"key":"2026020402535689500_bib121","doi-asserted-by":"crossref","first-page":"14384","DOI":"10.1073\/pnas.95.24.14384","article-title":"Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors","volume":"95","author":"Song","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020402535689500_bib122","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1089\/hum.2006.17.1177","article-title":"Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults","volume":"17","author":"Brantly","year":"2006","journal-title":"Hum Gene Ther"},{"key":"2026020402535689500_bib123","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jgm.896","article-title":"Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector","volume":"8","author":"Lu","year":"2006","journal-title":"J Gene Med"},{"key":"2026020402535689500_bib124","doi-asserted-by":"crossref","first-page":"16363","DOI":"10.1073\/pnas.0904514106","article-title":"Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy","volume":"106","author":"Brantly","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020402535689500_bib125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/hum.2010.118","article-title":"Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method","volume":"22","author":"Chulay","year":"2011","journal-title":"Hum Gene Ther"},{"key":"2026020402535689500_bib126","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1128\/JVI.73.7.6085-6088.1999","article-title":"Transduction of well-differentiated airway epithelium by recombinant adeno-associated virus is limited by vector entry","volume":"73","author":"Bals","year":"1999","journal-title":"J Virol"},{"key":"2026020402535689500_bib127","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1128\/jvi.69.4.2004-2015.1995","article-title":"Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses","volume":"69","author":"Yang","year":"1995","journal-title":"J Virol"},{"key":"2026020402535689500_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.2003.02124.x","article-title":"Immunological hurdles to lung gene therapy","volume":"132","author":"Ferrari","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"2026020402535689500_bib129","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1089\/hum.1998.9.18-2761","article-title":"Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia","volume":"9","author":"Duan","year":"1998","journal-title":"Hum Gene Ther"},{"key":"2026020402535689500_bib130","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/jgm.759","article-title":"Enhancing rAAV vector expression in the lung","volume":"7","author":"Virella-Lowell","year":"2005","journal-title":"J Gene Med"},{"key":"2026020402535689500_bib131","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/mt.2008.217","article-title":"Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of alpha-1-antitrypsin using invasive and noninvasive delivery","volume":"17","author":"Liqun Wang","year":"2009","journal-title":"Mol Ther"},{"key":"2026020402535689500_bib132","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/mt.2010.51","article-title":"Expression of human alpha1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs","volume":"18","author":"Halbert","year":"2010","journal-title":"Mol Ther"},{"key":"2026020402535689500_bib133","doi-asserted-by":"crossref","first-page":"12993","DOI":"10.1073\/pnas.0601433103","article-title":"Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered","volume":"103","author":"Limberis","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020402535689500_bib134","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1258\/la.2007.007055","article-title":"Oral instillation with surfactant phospholipid: a reliable alternative to intratracheal injection in mouse studies","volume":"42","author":"Yu","year":"2008","journal-title":"Lab Anim"},{"key":"2026020402535689500_bib135","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/mt.2008.261","article-title":"Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro","volume":"17","author":"Limberis","year":"2009","journal-title":"Mol Ther"},{"key":"2026020402535689500_bib136","first-page":"440","article-title":"Intrapleural \u2018outside-in\u2019 gene therapy: therapeutics for organs of the chest via gene transfer to the pleura","volume":"7","author":"Heguy","year":"2005","journal-title":"Curr Opin Mol Ther"},{"key":"2026020402535689500_bib137","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1089\/10430340260185102","article-title":"Gene transfer to the pleural mesothelium as a strategy to deliver proteins to the lung parenchyma","volume":"13","author":"Mae","year":"2002","journal-title":"Hum Gene Ther"},{"key":"2026020402535689500_bib138","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.thorsurg.2010.12.001","article-title":"Anatomy of the pleura","volume":"21","author":"Finley","year":"2011","journal-title":"Thorac Surg Clin"},{"key":"2026020402535689500_bib139","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0272-5231(21)00334-8","article-title":"Anatomy and physiology of the pleural space","volume":"6","author":"Wang","year":"1985","journal-title":"Clin Chest Med"},{"key":"2026020402535689500_bib140","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1164\/arrd.1984.130.2.267","article-title":"Role of pleural mesothelial cells in the production of the submesothelial connective tissue matrix of lung","volume":"130","author":"Rennard","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"2026020402535689500_bib141","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.resp.2007.07.002","article-title":"Pleural liquid and its exchanges","volume":"159","author":"Agostoni","year":"2007","journal-title":"Respir Physiol Neurobiol"},{"key":"2026020402535689500_bib142","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00063198-200107000-00002","article-title":"Normal volume and cellular contents of pleural fluid","volume":"7","author":"Noppen","year":"2001","journal-title":"Curr Opin Pulm Med"},{"key":"2026020402535689500_bib143","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1440-1843.2002.00404.x","article-title":"Mesothelial cells: their structure, function and role in serosal repair","volume":"7","author":"Mutsaers","year":"2002","journal-title":"Respirology"},{"key":"2026020402535689500_bib144","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/ajrccm.162.3.9910050","article-title":"Volume and cellular content of normal pleural fluid in humans examined by pleural lavage","volume":"162","author":"Noppen","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402535689500_bib145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1165\/ajrcmb.12.4.7695917","article-title":"Polarity of secretion of alpha 1-antitrypsin by human respiratory epithelial cells after adenoviral transfer of a human alpha 1-antitrypsin cDNA","volume":"12","author":"Siegfried","year":"1995","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020402535689500_bib146","first-page":"631","article-title":"Mesothelial cells","author":"Bernaudin","year":"1991","edition":"1st ed"},{"key":"2026020402535689500_bib147","doi-asserted-by":"crossref","first-page":"e93979","DOI":"10.1371\/journal.pone.0093979","article-title":"Active trafficking of alpha 1 antitrypsin across the lung endothelium","volume":"9","author":"Lockett","year":"2014","journal-title":"PLoS One"},{"key":"2026020402535689500_bib148","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/apha.12016","article-title":"Pleural function and lymphatics","volume":"207","author":"Negrini","year":"2013","journal-title":"Acta Physiol (Oxf)"},{"key":"2026020402535689500_bib149","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/humc.2013.168","article-title":"Intrapleural administration of an AAVrh.10 vector coding for human \u03b11-antitrypsin for the treatment of \u03b11-antitrypsin deficiency","volume":"24","author":"Chiuchiolo","year":"2013","journal-title":"Hum Gene Ther Clin Dev"},{"key":"2026020402535689500_bib150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/humc.2014.2513","article-title":"Phase I\/II study of intrapleural administration of a serotype rh.10 replication-deficient adeno-associated virus gene transfer vector expressing the human \u03b11-antitrypsin cDNA to individuals with \u03b11-antitrypsin deficiency","volume":"25","author":"Chiuchiolo","year":"2014","journal-title":"Hum Gene Ther Clin Dev"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/Supplement_4\/S352\/66667353\/annalsats_13_supplement_4_s352.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/Supplement_4\/S352\/66667353\/annalsats_13_supplement_4_s352.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:54:23Z","timestamp":1770191663000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/13\/Supplement_4\/S352\/8449167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,1]]},"references-count":150,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2016,8,1]]},"published-print":{"date-parts":[[2016,8,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201506-344kv","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,8]]},"published":{"date-parts":[[2016,8,1]]}}}